Addex Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	13	4	4	28	60	-
Market Cap Growth	-	-5.05%	-85.77%	-53.09%	-	-
Enterprise Value	9	-0	-3	6	39	-32
PE Ratio	-0.30	-0.30	-0.18	-1.66	-4.08	-
PS Ratio	6.44	1.93	2.56	8.07	13.52	-
PB Ratio	10.12	2.77	0.75	1.50	3.59	-
P/FCF Ratio	-0.40	-0.40	-0.23	-1.73	-4.29	-
P/OCF Ratio	-0.40	-0.40	-0.23	-1.73	-4.31	-
EV/Sales Ratio	4.48	-0.21	-2.00	1.72	8.83	-10.94
EV/EBITDA Ratio	0.04	0.04	0.14	-0.36	-2.90	2.18
EV/EBIT Ratio	0.03	0.03	0.14	-0.35	-2.81	2.13
EV/FCF Ratio	0.04	0.04	0.18	-0.37	-2.80	3.26
Debt / Equity Ratio	0.30	0.30	0.08	0.03	0.04	0.02
Debt / EBITDA Ratio	-0.03	-0.03	-0.02	-0.03	-0.05	-0.04
Debt / FCF Ratio	-0.04	-0.04	-0.02	-0.03	-0.05	-0.06
Quick Ratio	1.37	1.37	2.25	5.00	5.20	5.57
Current Ratio	1.46	1.46	2.38	5.31	5.38	5.70
Asset Turnover	0.24	0.24	0.12	0.14	0.17	0.08
Interest Coverage	-30.15	-30.15	-65.41	-242.63	-18.76	-68.29
Return on Equity (ROE)	-276.20%	-276.20%	-254.60%	-91.10%	-72.50%	-45.60%
Return on Assets (ROA)	-156.00%	-156.00%	-167.80%	-69.00%	-56.00%	-39.30%
Return on Capital (ROIC)	-690.11%	-690.11%	-388.20%	-89.05%	-80.67%	-56.01%
Earnings Yield	-99.60%	-332.73%	-562.40%	-60.34%	-24.52%	-
FCF Yield	-68.97%	-252.14%	-444.36%	-57.92%	-23.34%	-
Buyback Yield / Dilution	-97.79%	-97.79%	-42.03%	0.07%	-0.73%	-
Total Shareholder Return	-97.79%	-97.79%	-42.03%	0.07%	-0.73%	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).